Fund Holdings — Allostery Investments LP

Total Portfolio Value
$7.85M
Total Bought
$1.74M
Total Sold
$63.22M
Net Transaction
-$61.48M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
REZOLUTE INC(RZLT)0119,294+119,29405326.78%+532
AKERO THERAPEUTICS INC18,00022,500+4,5007291,20115.29%+472
FULCRUM THERAPEUTICS INC(FULC)040,353+40,35302783.54%+278
TANGO THERAPEUTICS INC(TNGX)040,000+40,00002052.61%+205
TOURMALINE BIO INC09,356+9,35601501.91%+150
NEKTAR THERAPEUTICS(NKTR)04,000+4,00001031.32%+103
LEXEO THERAPEUTICS INC(LXEO)5,0540-5,054180—-18
LEGEND BIOTECH CORP(LEGN)4,7504,000-7501611421.81%-19
EDGEWISE THERAPEUTICS INC(EWTX)3,0000-3,000660—-66
PROMIS NEUROSCIENCES INC233,703155,720-77,983165760.97%-89
ARCUTIS BIOTHERAPEUTICS INC(ARQT)7,5000-7,5001170—-117
WAVE LIFE SCIENCES LTD(WVE)17,5000-17,5001410—-141
VIR BIOTECHNOLOGY INC(VIR)22,2020-22,2021440—-144
AMYLYX PHARMACEUTICALS INC(AMLX)266,099120,119-145,9809427709.81%-172
89BIO INC25,0000-25,0001820—-182
MADRIGAL PHARMACEUTICALS INC(MDGL)6000-6001990—-199
ORUKA THERAPEUTICS INC(ORKA)20,0000-20,0002050—-205
CLIMB BIO INC(CLYM)244,9880-244,9882990—-299
ELEDON PHARMACEUTICALS INC(ELDN)100,0000-100,0003390—-339
RALLYBIO CORP(RLYB)752,2350-752,2354920—-492
BIOMX INC(PHGE)940,6290-940,6295230—-523
VERONA PHARMA PLC12,5002,500-10,0007942363.01%-557
CONTEXT THERAPEUTICS INC(CNTX)950,1660-950,1665820—-582
PLIANT THERAPEUTICS INC(PLRX)441,6860-441,6865960—-596
GOSSAMER BIO INC(GOSS)613,0280-613,0286740—-674
TARSUS PHARMACEUTICALS INC(TARS)13,6000-13,6006990—-699
INSMED INC(INSM)10,0000-10,0007630—-763
AVALO THERAPEUTICS INC(AVTX)107,1419,000-98,141858450.57%-813
XENON PHARMACEUTICALS INC(XENE)30,0000-30,0001,0070—-1,006
IONIS PHARMACEUTICALS INC(IONS)35,0000-35,0001,0560—-1,056
VAXCYTE INC(PCVX)32,0000-32,0001,2080—-1,208
SOLENO THERAPEUTICS INC20,0000-20,0001,4290—-1,429
BEAM THERAPEUTICS INC(BEAM)92,7540-92,7541,8110—-1,811
SPRINGWORKS THERAPEUTICS INC52,5000-52,5002,3170—-2,317
BRIDGEBIO PHARMA INC(BBIO)80,0004,000-76,0002,7661732.20%-2,593
CYTOKINETICS INC(CYTK)70,0005,000-65,0002,8131652.10%-2,648
ARCELLX INC
COMMON STOCK
44,0001,000-43,0002,886660.84%-2,821
ZURA BIO LTD(ZURA)2,329,3840-2,329,3843,0050—-3,005
AEROVATE THERAPEUTICS INC1,421,5680-1,421,5683,5680—-3,568
ALKERMES PLC(ALKS)115,0000-115,0003,7970—-3,797
APOGEE THERAPEUTICS INC(APGE)110,0006,000-104,0004,1102613.32%-3,849
EVOLUS INC(EOLS)412,75460,000-352,7544,9655537.04%-4,413
MERUS N V124,6579,000-115,6575,2474736.03%-4,773
CENTESSA PHARMACEUTICALS PLC382,52452,500-330,0245,5016908.79%-4,811
KALVISTA PHARMACEUTICALS INC458,30240,000-418,3025,2894525.76%-4,837
ABIVAX SA(ABVX)1,099,654167,350-932,3046,8731,28016.31%-5,593
Page 1 of 1
Allostery Investments LP — 13F Holdings — Q2 2025 | TickerTrail